AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
167.76
+1.19 (0.71%)
At close: Nov 20, 2024, 4:00 PM
167.68
-0.08 (-0.05%)
After-hours: Nov 20, 2024, 7:52 PM EST

AbbVie Revenue

AbbVie had revenue of $14.46B in the quarter ending September 30, 2024, with 3.83% growth. This brings the company's revenue in the last twelve months to $55.53B, up 0.72% year-over-year. In the year 2023, AbbVie had annual revenue of $54.32B, down -6.44%.

Revenue (ttm)
$55.53B
Revenue Growth
+0.72%
P/S Ratio
5.34
Revenue / Employee
$1,110,660
Employees
50,000
Market Cap
296.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202354.32B-3.74B-6.44%
Dec 31, 202258.05B1.86B3.30%
Dec 31, 202156.20B10.39B22.69%
Dec 31, 202045.80B12.54B37.69%
Dec 31, 201933.27B513.00M1.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 393.90B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher 42.37B
Abbott Laboratories 41.22B
Eli Lilly 40.86B
Revenue Rankings